Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Authors:

Abstract
No abstract available
Funding Information
  • Japan Agency for Medical Research and Development (JP18ck0106214)

This publication has 18 references indexed in Scilit: